Alpha memo: nicotinamide exercise performance

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Explicitly disentangle the confounded variables between the two receipts: state that species (rat vs human), dosing duration (21-day chronic vs single acute dose), and baseline NAD(P)H status all differ, and that the 'baseline deficiency moderates benefit' interpretation is one of several possible explanations rather than the only supported one.
2. Soften the central claim to reflect this ambiguity — e.g., 'context-dependent' rather than specifically 'baseline NAD(P)H status and age'-moderated, or explicitly frame the age/baseline hypothesis as a tentative moderation claim awaiting controlled chronic-in-deficient-older-humans testing.
3. Add a brief note on the small sample size (n=12 per group) of Receipt 2 as a limitation on the strength of the human benefit signal.

Major issues

• The central 'context-split' framing implies a unified moderation hypothesis (baseline NAD(P)H status and age), but the two receipts differ on multiple dimensions simultaneously (species, acute vs chronic, dose, route, baseline status measurement) — the memo attributes the divergence to baseline NAD(P)H/age without explicitly acknowledging that the age and baseline NAD(P)H variables are confounded with species and dosing-duration variables, making the 'deficiency-modulated benefit' hypothesis one of several equally plausible explanations.
• The abstract claims chronic dosing 'tends to reduce performance in young rats while acute dosing appears to improve redox and performance in older humans' — Receipt 1 explicitly reports 'tendency towards worse physical performance' (not a statistically significant reduction), which is somewhat softened in the memo but the abstract phrasing 'tends to reduce' is acceptable given the source language.

Minor issues

• Receipt 1 is from 2016 and Receipt 2 from 2020; both are within the 5-year recency window if measured from 2021, but by 2026 standards Receipt 1 is a decade old — worth noting that the 'surprising' framing rests on a single pair of older receipts.
• The falsifier is well-specified but the memo could additionally note that Receipt 2's n=12 per group is small, limiting the strength of the acute/older benefit claim.

Reviewer note

This is a tightly bounded alpha-memo built on a well-matched two-receipt pair: Receipt 1 (chronic NR in young rats, impaired performance tendency) and Receipt 2 (acute NR in young vs older men, benefit specifically in older/deficient subgroup). The two sources genuinely speak to each other — Receipt 2 explicitly cites Receipt 1 as motivation, which strengthens the pairing. The one-sentence alpha, the 'why surprising' framing, and the falsifier are all clearly articulated and proportionate. The main issue is confounded-variable framing. The memo attributes the opposite directions to baseline NAD(P)H status and age, but the two receipts also differ on species, dosing duration (21-day chronic vs single acute dose), and route. The 'deficiency-modulated benefit' interpretation is plausible but is not the only reading; chronic-vs-acute and species effects are equally viable explanations. The memo should acknowledge this. This keeps the memo within revise rather than reject territory because the underlying receipts are real, well-matched, and the bounded signal (NR's exercise effects are context-dependent, not uniformly ergogenic) is clearly supported — only the specific moderation mechanism is mildly overclaimed. Source grounding is strong: both DOIs resolve to real publications, Receipt 2's excerpt explicitly references Receipt 1, and the cited findings match the abstracts. Limitations are present (species/duration/modality differences) but could be sharper about the confound structure. Gaps and falsifier are well-specified and actionable.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v11-research-synthesis